AnalysisNews

SNN today

$31.15-$0.86 (-2.69%)close Nov 6, 2026

Trend

DailyUptrend (confirmed)

4 hourStrong Bullish

1 hourStrong Bullish

15 minSymmetric Triangle

5 minDescending Triangle

Daily trend turns down below $28.69

Key levels

Resistance$32.06

Resistance$31.21

Support$30.41

Support$29.60

Latest news & SEC filings

AnalystNov 5, 2026Smith & Nephew Sees Analyst Target Change at UBS

DealNov 4, 2026Smith & Nephew halts combination discussions with Johnson & Johnson orthopedics business, trims 2026 forecast

EarningsNov 4, 2026Smith+Nephew Q3 revenue up 3.4% to $1.551B, half of $500M buyback done

All SNN news →

About Smith & Nephew

Smith & Nephew is a medical technology company that repairs, regenerates, and replaces soft and hard tissue. It operates through three global units: Orthopaedics (hip, knee, and shoulder implants, trauma products, and robotic surgery systems), Sports Medicine & ENT (instruments for soft tissue repair and ear, nose, and throat procedures), and Advanced Wound Management (products for hard-to-heal wounds). Its customers are hospitals, surgeons, and healthcare providers, and it sells in about 100 countries.

Based on the company's 20-F filed Mar 16, 2026.

NYSE · Healthcare

SMITH & NEPHEW PLC (SNN)

$31.15-0.86 (-2.69%)
WATCHLISTGrade: BRisk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
27.6328.8430.0431.2531.15Oct 6Oct 14Oct 22Oct 30
High31.27
Low30.68
Open30.73
Volume1.70M
Avg Vol1.34M
VWAP31.06
30d High32.46
30d Low26.42
30d Chg+15.03%
See full chart with real-time data

What Is the Price Target for SNN?

SEPT Low Target

$32.32

SEPT Mid Target

$32.32

SEPT High Target

$32.32

Analyst Consensus

$32.32

Current: $31.70Upside: +2.0%Confidence: 40%Method: Analyst Consensus

Is SNN a Buy or Sell Right Now?

63
Investability Score
WATCHLIST12-18 months

Thesis

  • •Revenue growing 6.1% YoY with STABLE trend — consistent growth.
  • •Smart money flows are positive — institutional and insider activity supports thesis.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SNN.

Start Free Trial →

Is SNN Overvalued or Undervalued?

Valuation Verdict

FAIR

Methods Used

P/E Forward, Analyst Consensus

Fair Value

$33.94

60

Moat Score

NARROW

6/9

Piotroski Score

4.9

Altman Z-Score

What Is Smart Money Doing with SNN?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

BUYING

1 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

MEDIUM

Signal: NEUTRAL

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

SNN Growth Story

Revenue YoY

6.1%

3yr Revenue CAGR

5.7%

EPS Growth YoY

52.34%

FCF Growth YoY

N/A%

Revenue Trend

STABLE

Dark Pool Trades for SNN

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for SNN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
21:00:22$31.152,120$$66KSELL
20:58:33$31.161,200$$37KMIDPOINT
20:55:53$31.141,037$$32KBUY
20:35:32$31.021,000$$31KMIDPOINT
20:23:51$31.081,000$$31KBUY

5 dark pool trades shown · $$198K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for SMITH & NEPHEW PLC (SNN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings intelligence, and a complete investment thesis with entry and exit recommendations.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...

Sign Up Free — Download AI Report PDF →

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

Compare SEPT with other platforms

SEPT vs TradingViewSEPT vs BloombergSEPT vs Unusual WhalesSEPT vs SpotGammaSEPT vs TrendSpiderBest AI Trading Platforms
What is dark pool trading?How to read options flowGEX explainedSmart money trackingAI stock analysisEarn money on SEPT

About SEPT Investing

SEPT Investing tracks 13,000+ stocks with live charts, trend and key-level tracking, dark pool and options flow, insider and congress trades, SEC filings and news alerts.

Disclaimer: This page is for informational purposes only. It does not constitute financial advice. Past performance does not guarantee future results. Always do your own research before making investment decisions.

SNN — frequently asked questions

What is SNN stock price today?

SMITH & NEPHEW PLC (SNN) is at $31.15, down 2.69% (-$0.86) at the Nov 6, 2026 close.

Why is SNN stock moving today?

Latest SNN news — Nov 5, 2026: Smith & Nephew Sees Analyst Target Change at UBS · Nov 4, 2026: Smith & Nephew halts combination discussions with Johnson & Johnson orthopedics business, trims 2026 forecast

What is the SNN price target?

The average analyst price target for SNN is $32.32, ranging from $32 to $32.

What do analysts rate SNN?

Analyst ratings for SNN: 0 Buy, 1 Hold, 0 Sell — consensus Hold.

Did SNN beat earnings?

SNN last reported on Aug 4, 2026: EPS $0.95 vs $0.94 expected — a beat of 0.7%.

Does SNN pay a dividend?

Yes. SNN's dividend yield is 1.27%.

How much debt does SNN have?

SMITH & NEPHEW PLC reported $3.1B of debt and $557M of cash (Dec 31, 2025).

What are SNN support and resistance levels?

Support: $30.41, $29.60, $28.69. Resistance: $31.21, $32.06, $32.91.

What are insiders doing with SNN?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on SNN?

Nov 5, 2026: Smith & Nephew Sees Analyst Target Change at UBS · Nov 4, 2026: Smith & Nephew halts combination discussions with Johnson & Johnson orthopedics business, trims 2026 forecast · Nov 4, 2026: Smith+Nephew Q3 revenue up 3.4% to $1.551B, half of $500M buyback done